The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
The effect of the Rochagan on radiolabeling with (99m)Tc
Corresponding Author(s) : C. M. C. X. Holanda
cechol@ufrnet.br
Cellular and Molecular Biology,
Vol. 55 No. 3: First symposium on internal dosimetry applied to nuclear medicine (DOSIMN) 2008 Part 1
Abstract
Radionuclides are used in nuclear medicine by variety of diagnostic procedures. The labeling of red blood cells (RBC) with 99mTc is a current method applied in clinical nuclear medicine. Drugs can alter this labeling and modify the disposition of the radiopharmaceuticals. The influence of Rochagan on the labeling of blood constituents with 99mTc was reported. Samples of blood were incubated with different concentrations of Rochagan (0%; 6.25%; 12.5%; 25%; 50%; 100%). Stannous chloride and 99mTc (3.7MBq/mL) were added. Plasma (P) and (RBC) were isolated and precipitated with thricloroacetic acid 5%. The insoluble (IF) and soluble fractions (SF) were separated. The %ATI in RBC, IF-P and IF-RBC were calculated. The %ATI on RBC decreased significantly (p<0.05) from control to all concentrations of Rochagan, respectively: 90.15±0.14(control) to 70.80±4.21; to 64.36±0.33; to 57.30±1.56; to 50.28±2.71; to 42.41±2.24; on IF-RBC, respectively: 84.70±0.87(control) to 67.16±4.38; to 63.63±2.92; to 59.02±3.17; to 43.75±1.00; to 24.15±0.94 and also on IF-P, respectively: 83.46±1.09(control) to 50.90±3.36; to 35.46±4.13; to 35.78±2.31; to 28.74±3.09; to 19.66±1.34. The analyses were performed by T-Student and Mann Whitney tests, p<0.05. This effect was probably due to products present in Rochagan that may complex with ions or have a direct/indirect effect on intracellular stannous ion concentration.
Keywords
Rochagan
Chagas' disease
technetium-99m
blood constituents.
Holanda, C. M. C. X., Silva-Júnior, M. F., Alves, R. C., Barbosa, V. S. A., Silva, R. P., Rocha, L. G., & Medeiros, A. C. (2009). The effect of the Rochagan on radiolabeling with (99m)Tc. Cellular and Molecular Biology, 55(3), 23–28. Retrieved from https://mail.cellmolbiol.org/index.php/CMB/article/view/1022
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX